LIP
ABOS icon

Lighthouse Investment Partners’s Acumen Pharmaceuticals ABOS Stock Holding History

Lighthouse Investment Partners’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,263
Closed -$60.8K – 265
2022
Q4 		$60.8K Buy
+11,263
New +$75.7K 0.01% 243

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Lighthouse Investment Partners's ABOS Position: Q1 2023 in Review

Lighthouse Investment Partners sold out of Acumen Pharmaceuticals (ABOS) in Q1 2023, closing a stake of 11,263 shares — an estimated $60.8K sold.

Lighthouse Investment Partners first reported a position in ABOS in Q4 2022 and held it in 1 quarter. The position peaked at $60.8K in Q4 2022. 61 funds tracked by Wall St. Rank hold ABOS as of Q1 2023.

  • Lighthouse Investment Partners reported no remaining Acumen Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Lighthouse Investment Partners sold 11,263 Acumen Pharmaceuticals shares in Q1 2023, an estimated $60.8K.
  • Lighthouse Investment Partners first reported a position in Acumen Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • Lighthouse Investment Partners's Acumen Pharmaceuticals position peaked at $60.8K in Q4 2022.
  • 61 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2023.

Based on Lighthouse Investment Partners's 13F filing for Q1 2023, filed 15 May 2023.